Osteosarcoma is the bone tumor that most commonly affects children, adolescents, and young adults. Before 1970, treatment primarily included surgical resection. However, the introduction of ...

Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care. While genetic ...

Backed by a $15 million investment, families, funders, and researchers unite to advance long-awaited breakthroughs against this deadly childhood bone cancer "This Break Through Cancer project brings a ...

Recently, a research team led by Professor Xie Huiqi at Sichuan University conducted a systematic review of dual-function ...

Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient's immune cells to target cancer cells. While successful in some types of leukemia, the approach has yet to realize its ...

Scientists have demonstrated a new potential treatment for bone cancer. A bioactive glass laced with a toxic metal was able to kill up to 99% of the cancer without harming healthy cells, and could ...

About 5% of childhood cancers are bone cancer. It can cause pain, swelling, fractures, and interference with everyday activities. The above information comes from a 2022 paper. Diagnosis involves a ...

Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor, ...

(RTTNews) - OS Therapies, Inc. (OSTX), a clinical-stage biopharma company specializing in immunotherapies and antibody-drug conjugates, has launched a new subsidiary, OS Animal Health, Inc., to lead ...